NEW—Correspondence reports initial analysis of neutralising antibody activity against #SARS-CoV-2 variants of concern B.1.617.2 and B.1.351 elicited by partial or full vaccination with #BNT162b2 (#Pfizer-BioNTech).
Read hubs.li/H0PzQ7b0. Figure from appendix. @TheCrick
Thread
Nenhum Voo ainda